Finance

Lists
NRXP:NASDAQ
NRX Pharmaceuticals Inc
US$2,85
-1,38%
(-0,040) 1D
US$2,85
0,00% (0,00)
After hours
Closed: 9 ຕ.ລ., 16 ໂມງ 0 ນາທີ 00 ວິນາທີ GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NRXP...
Open
US$2,89
High
US$2,89
Low
US$2,82
Mkt. cap
123,39 ລ້ານ
Avg. vol.
631,46 ພັນ
Volume
289,40 ພັນ
52-wk high
US$5,06
52-wk low
US$1,62
EPS
US$-0,74
Beta
2,08
Shares outstanding
43,30 ລ້ານ
No. of employees
29
Open
US$2,89
High
US$2,89
Low
US$2,82
Mkt. cap
123,39 ລ້ານ
Avg. vol.
631,46 ພັນ
Volume
289,40 ພັນ
52-wk high
US$5,06
52-wk low
US$1,62
EPS
US$-0,74
Beta
2,08
Shares outstanding
43,30 ລ້ານ
No. of employees
29
News stories
From web sources and news partners
About NRX Pharmaceuticals Inc
CEO-
Employees29
Founded2015
HeadquartersWilmington, ເດລາແວ, ສະຫະລັດ
SectorPharmaceutical industry
Analyst ratings
Based on 3 analysts giving stock ratings to NRXP in the past 3 months
Strong buy
Buy
3
Hold
0
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for NRXP in the last 3 months.
Highest
Current US$2,85
US$50,00 (+1.654,39%)
Average
US$35,00 (+1.128,07%)
Lowest
US$10,00 (+250,88%)
Analyst
Recommendation
Action
Price target
Projected
Date
Edward Woo
Ascendiant
Buy
Maintained
US$50,00
+1.654,4%
09/30/2026
Patrick Trucchio
H.C. Wainwright
Buy
Reiterated
US$45,00
+1.478,9%
09/21/2026
Thomas Shrader
BTIG
Buy
Maintained
US$10,00
+250,9%
09/14/2026
Elemer Piros
Lucid Capital
Buy
Initiated
US$49,00
+1.619,3%
05/13/2026
Jason Kolbert
D. Boral Capital
Buy
Maintained
US$34,00
+1.093%
04/20/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
ກ.ຍ. 2025
ທ.ວ. 2025
ມ.ນ. 2026
ມິ.ຖ. 2026
Revenue
242,00 ພັນ
983,00 ພັນ
1,07 ລ້ານ
1,10 ລ້ານ
Cost of goods sold
97,00 ພັນ
408,00 ພັນ
631,00 ພັນ
675,00 ພັນ
Cost of revenue
97,00 ພັນ
408,00 ພັນ
631,00 ພັນ
675,00 ພັນ
Research and development expenses
1,43 ລ້ານ
558,00 ພັນ
1,31 ລ້ານ
2,12 ລ້ານ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2,81 ລ້ານ
4,57 ລ້ານ
3,81 ລ້ານ
4,74 ລ້ານ
Operating expense
4,26 ລ້ານ
5,17 ລ້ານ
5,18 ລ້ານ
6,93 ລ້ານ
Total operating expenses
4,36 ລ້ານ
5,58 ລ້ານ
5,82 ລ້ານ
7,60 ລ້ານ
Operating income
-4,12 ລ້ານ
-4,59 ລ້ານ
-4,75 ລ້ານ
-6,50 ລ້ານ
Other non operating income
-366,00 ພັນ
1,59 ລ້ານ
3,54 ລ້ານ
-9,78 ລ້ານ
EBT including unusual items
-5,89 ລ້ານ
360,00 ພັນ
-1,43 ລ້ານ
-16,52 ລ້ານ
EBT excluding unusual items
-4,48 ລ້ານ
-3,67 ລ້ານ
-1,44 ລ້ານ
-16,52 ລ້ານ
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-5,89 ລ້ານ
360,00 ພັນ
-1,43 ລ້ານ
-16,52 ລ້ານ
Net profit margin
-2.433,88%
36,62%
-133,90%
-1.500,45%
Earnings per share
-0,51
0,18
-0,04
-0,24
Interest and investment income
2,00 ພັນ
4,00 ພັນ
5,00 ພັນ
6,00 ພັນ
Interest expense
-
-671,00 ພັນ
-233,00 ພັນ
-240,00 ພັນ
Net interest expenses
2,00 ພັນ
-667,00 ພັນ
-228,00 ພັນ
-234,00 ພັນ
Depreciation and amortization charges
26,00 ພັນ
42,00 ພັນ
63,00 ພັນ
66,00 ພັນ
EBITDA
-4,11 ລ້ານ
-4,55 ລ້ານ
-4,68 ລ້ານ
-6,43 ລ້ານ
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
ແອັບຂອງ Google